GILD vs LXFR · P/E 18, rev $7.80B vs P/E 16, rev $181.4M
Gilead Sciences Inc (GILD) versus Luxfer Holdings PLC (LXFR) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US. It is led by Daniel P. O'Day.
Luxfer Holdings PLC (LXFR) is a specialty industrial machinery company listed on US.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported LXFR revenue for 2026-06-28 was $181.4M. Net income was $8.4M. LXFR currently screens at market cap $345.4M and trailing P/E 16.3.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. LXFR currently screens at market cap $345.4M and trailing P/E 16.3.
Not investment advice. Open the GILD and LXFR stock pages for the full models.
Not investment advice.